117th Congress · SENATE BILLBILL

S. 250 — Fairness in Orphan Drug Exclusivity Act

“A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.”

Health

Introduced Feb 4, 2021

Last action Feb 4, 2021

Pipeline · Bill → Law

Step 1

Introduced

Feb 4, 2021

Step 2

Referred

Feb 4, 2021

HELP

Step 3

Committee

Step 4

Senate

Step 5

House floor

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in Senate

Timeline · 2 actions

Feb 4, 2021

Introduced in Senate

Feb 4, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.